Trial Profile
Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2015
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Infliximab (Primary)
- Indications Crohn's disease; Ulcerative colitis
- Focus Therapeutic Use
- 27 Dec 2014 New trial record